Cross-Sector entity
Uganda is most often covered alongside World Health Organization, which appears in 5 of these 8 stories. The 25-day window averages about 2.2 stories each week. The busiest single day carried 2. Coverage clusters in clinical-trial, which accounts for 3 of those 8, with the remainder spread across 4 other categories.
8 verified stories tracked
Last mentioned: Aug 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 75 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Uganda is most often covered alongside World Health Organization, which appears in 5 of these 8 stories. The 25-day window averages about 2.2 stories each week. The busiest single day carried 2. Coverage clusters in clinical-trial, which accounts for 3 of those 8, with the remainder spread across 4 other categories. The tracked stories average 2.6 original sources each. 75% of these stories carry negative sentiment. We currently track 8 Cross-Sector stories that mention Uganda, published between July 20, 2026 and August 13, 2026.
Computed from the 8 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Uganda. Shared-story counts are live from our verified record — not editorial picks.
NPR report details mixed rollout reviews in Uganda
A syndicated story from Kalisizo, Uganda highlights participant Irene's experience, the drug's six-month protection, and ongoing implementation challenges.
High-level international visits
WHO Director-General Tedros Adhanom Ghebreyesus arrives in Kinshasa; Africa CDC head Jean Kaseya visits Bunia, warning that 80% of cases are from community spread.
Leadership Visits and Latest Data Released
Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
Healthcare workers' ultimatum
Healthcare workers in Mongbwalu issue a 24-hour ultimatum over unpaid wages, threatening escalation.
WHO sounds alarm
WHO reports that 80% of new cases are from unknown chains of transmission; striking workers agree to return if paid within 72 hours.
Health worker strike
Dozens of healthcare workers at an Ebola treatment centre in Bunia go on strike over unpaid salaries and bonuses.
Record outbreak data confirmed
Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
Clinical trials for treatments launched
Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
Kenya court suspends U.S.-backed facility
A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
Uganda Declared Ebola‑Free
Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
Uganda declared Ebola-free
Uganda discharges its last Ebola patient and declares the country free of the disease.
Ebola outbreak officially declared
Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
Outbreak identified
Congo detects an outbreak of the rare Bundibugyo Ebola virus in the eastern part of the country.
First U.S. doctor infected and evacuated
An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.
PURPOSE 1 and PURPOSE 2 deliver unprecedented efficacy
An independent monitoring committee concluded lenacapavir was so effective that the randomized phase of both trials was halted early.
A twice-yearly injectable PrEP, lenacapavir showed unprecedented efficacy in the PURPOSE 1 and 2 trials, yet its rollout in Uganda is drawing mixed reviews. For health systems, the drug's adherence-friendly profile must clear delivery, access, and stigma barriers to achieve population-level impact.
A prolonged Strait of Hormuz disruption is exposing deep structural weaknesses in Africa's oil-importing economies, putting sovereign credit, inflation and investment themes under pressure. The continent’s paltry 10% manufacturing GDP share highlights the urgent need for a new growth model centred on energy independence and regional integration.
Source: allafrica.com · theconversation.com
Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Source: wfmj.com · orlandosentinel.com
The Bundibugyo Ebola outbreak in DRC has killed 1,700 people as community transmission drives 80% of new cases, revealing critical gaps in digital contact tracing and surveillance. With no approved vaccines, health IT innovators face an urgent call to deploy mobile tracing, AI analytics, and rapid diagnostics. Ongoing clinical trials may offer hope, but the immediate need is for tech-enabled outbreak management.
Source: MedPage Today · greatlakesadvocate.com.au
The record Ebola outbreak in Congo surpasses 1,830 cases and 648 deaths, with a second U.S. humanitarian worker now infected. The public health response faces severe funding and security obstacles, while experimental treatments enter clinical trials.
With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Source: wtvq.com
Congo’s overstretched health system is shown by 80% of new Ebola cases arising outside contact lists, a worker strike, and a $300M funding gap—highlighting the need for digital surveillance and workforce stability.
With 80% of new Ebola cases from unknown chains and the rare Bundibugyo strain lacking any approved vaccine or treatment, this outbreak exposes a critical gap in the biopharma pipeline and may catalyse urgent R&D investment.
